Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-58P, also referred to as "RNA, U6 small nuclear 58, pseudogene," is a pseudogene of a small nuclear RNA (snRNA) originally involved in the splicing of pre-mRNA as part of the spliceosome machinery[7][2]. Functional U6 snRNA is an essential and highly conserved component of the spliceosomal complex, crucial for catalyzing intron removal from pre-messenger RNA[5]. However, because RNU6-58P is annotated as a pseudogene, it is generally regarded as a non-functional genomic copy and does not contribute to snRNP-mediated catalysis or splicing[7][2]. Pseudogenes typically arise from duplication or retrotransposition events and lack coding or regulatory potential required for normal cellular roles. No evidence supports its use as a therapeutic target or biomarker, and there are no drugs known to interact with this gene. Supporting details: - This gene is listed as a pseudogene, meaning it is not expected to produce a functional RNA product and is not involved directly in any known biological or disease pathways[7][2]. - No alternative molecular functions, drug interactions, or disease roles are attributed to it. - It has standard identifiers such as HGNC:42548, NCBI Gene: 100873766, and Ensembl: ENSG00000252952[7][2]. Note: This entry refers specifically to a pseudogene rather than the functional U6 small nuclear RNA. Functional U6 snRNA is important in RNA processing and splicing, but the pseudogene copy RNU6-58P does not share these activities[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 58, pseudogene (RNU6-58P).